ST Pharm Co.,Ltd. (237690.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap2.45T
Enterprise Value2.5T
P/E Ratio26.97
PEG Ratio0.23
Price/Sales Ratio5.38
Price/Book Ratio3.29
Enterprise/Revenue5.43
Enterprise/EBITDA21.9

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.2
Operating Margin0.18
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.13

Income Statement

Revenue331.55B
Revenue/Share18,591.27
Gross Profit129.32B
EBITDA84.4B
Net Income54.99B
Diluted EPS2,688.35

Balance Sheet

Total Cash183.41B
Total Cash/Share8,826.3
Total Debt74.81B
Total Debt/Equity0.12
Current Ratio2.28
Book Value Per Share30,272.9

Price History

52-Week Change8.37
52-Week High172,100
52-Week Low84,100
Moving Average 50 Days114,578
Moving Average 200 Days129,733

Statistics

Average Volume157,798
Shares Outstanding20.84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield0.5
Payout Ratio0.14
Last Split FactorN/A
Last Split DateN/A
AD